Multi-Center Comparison of Response to a Single Tablet of Sumatriptan 85 mg and Naproxen 500 mg vs Usual Therapy Treating Multiple Migraine Attacks as Measured by the Completeness of Response Survey - Cady, Roger; Banks, Jim; Nett, Robert B.; Goldstein, Jerome; Bennett, Nathan; Turner, Ira M.; Ruoff, Gary E.; Landy, Stephen H.; Farmer, Kathleen; Juhász, Márta; Tarrasch, Jeanne; Runken, M. Chris (Headache, 2011)
Keywords: Acute Disease; acute migraine; Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal - administration & dosage; Biological and medical sciences; Cardiovascular system; Drug Therapy, Combination; Female; Headache Impact Test; Headaches; Health Surveys; Humans; Male; Medical sciences; Middle Aged; Migraine; migraine symptom resolution; Migraine with Aura - drug therapy; Migraine with Aura - physiopathology; Migraine without Aura - drug therapy; Migraine without Aura - physiopathology; Naproxen - administration & dosage; Neurology; patient satisfaction; Pharmacology. Drug treatments; Recovery of Function; Revised Patient Perception of Migraine Questionnaire; Serotonin 5-HT1 Receptor Agonists - administration & dosage; SumaRT/Nap; Sumatriptan - administration & dosage; Vascular diseases and vascular malformations of the nervous system; Vasodilator agents. Cerebral vasodilators; Young Adult; Prostaglandin-endoperoxide synthase; Headache; Agonist; Sumatriptan; Cardiovascular disease; 5-HT1 Serotonine receptor; Headache Impact Test; Serotonin agonist; Vascular disease; SumaRT/Nap; acute migraine; Pain; Naproxen; Triptan derivatives; Arylpropionic acid derivatives; Tablet; Neurological disorder; Cerebrovascular disease; migraine symptom resolution; Human; Nervous system diseases; Revised Patient Perception of Migraine Questionnaire; Enzyme; Antimigrainous agent; Migraine; Enzyme inhibitor; Cerebral disorder; Non steroidal antiinflammatory agent; patient satisfaction; Analgesic; Treatment; Central nervous system disease; Antipyretic; Perception; Oxidoreductases; Comparative study